4.5 Article

Potential of an anti-bevacizumab idiotype scFv DNA-based immunization to elicit VEGF-binding antibody response

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Biochemistry & Molecular Biology

A Structural Overview of Vascular Endothelial Growth Factors Pharmacological Ligands: From Macromolecules to Designed Peptidomimetics

Xiaoqing Ye et al.

Summary: The VEGF family of growth factors plays a crucial role in vasculogenesis and angiogenesis, with blocking ligands developed to study their activities and potential therapeutic applications in cancer and age-related macular degeneration. There is a trend towards developing smaller ligands like nanobodies and peptides with improved properties such as serum stability and greater affinity, but there is still a scarcity of small molecular entities and a lack of small organic molecule ligands targeting VEGF members other than VEGF-A. Future developments in this area are expected in the coming years.

MOLECULES (2021)

Review Biochemistry & Molecular Biology

SeFv Improvement Approaches

Peyman Bemani et al.

PROTEIN AND PEPTIDE LETTERS (2018)

Review Biochemical Research Methods

Overlooked benefits of using polyclonal antibodies

Carl A. Ascoli et al.

BIOTECHNIQUES (2018)

Review Immunology

Molecular mechanisms for enhanced DNA vaccine immunogenicity

Lei Li et al.

EXPERT REVIEW OF VACCINES (2016)

Article Biotechnology & Applied Microbiology

Expression of VH-linker-VL orientation-dependent single-chain Fv antibody fragment derived from hybridoma 2E6 against aflatoxin B1 in Escherichia coli

Aiping Liu et al.

JOURNAL OF INDUSTRIAL MICROBIOLOGY & BIOTECHNOLOGY (2015)